Curative Biotechnology, Inc., a biopharmaceutical company, focuses on identifying, in licensing, and developing therapeutic drug candidates for rare disease indications. It develops Metformin Reformulation to treat intermediate dry macular ...
Leadership
Paul M. Michaels
President & Executive Chairman
I. Richard Garr Esq., J.D.
CEO, CFO, Principal Accounting Officer & General Counsel
Pam Bisikirski
Vice President of Communications
Ronald Bordens Ph.D.
Executive VP of Process Product Drug Development and Member of Scientific & Clinical Advisory Board
